DavosPharma

CMC & Manufacturing > Drug Product (Fill/Finish)

DavosPharma was established in 1972. Initially specializing in the oil-based commodity and specialty chemicals market, the market evolved, and we rose to meet the needs of its clients. Gradually, we moved into custom manufacturing of raw materials and intermediates for specialty chemicals and into the outsourcing model for custom starting materials and advanced intermediates.

Today, DavosPharma continues to grow and expand to meet the needs of the marketplace. Our unique experience combined with the skills of our talented Tech Ops Team positions us to offer our clients the tremendous technical capabilities of manufacturers worldwide. Our staff offers practical experience in dealing with process development, formulation, scale-up, tech transfers, government regulations, shipping, and logistics. We actively manage our custom projects and continue to be an integral part of the science until delivery and beyond.

In addition to these services, DavosPharma offers an Integrated IND program to address common challenges and hurdles experienced by Virtual and Small Pharma. The Integrated IND program pairs our expertise with personnel who are industry leaders in toxicology, ADME, DMPK, regulatory affairs, and clinical oversight. Our team is assembled based on the needs and objectives of our client. The team is assigned for the entire lifetime of your project from initial study planning, ongoing management, and all regulatory filings. With DavosPharma’s integrated IND program, Virtual and Small Pharma can keep their overhead costs low while still being equipped with a full development team to advance their lead asset.

Contact

Matt Cwiklinski Director, Business Development Phone: 414.687.0933
Vance Lyon Senior Director Phone: 845.987.0027
davos.com/
600 E Crescent Ave. Upper Saddle River, NJ 07458 United States